These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11731954)

  • 1. Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple.
    Romano L; Venturi G; Vivarelli A; Galli L; Zazzi M
    Clin Infect Dis; 2002 Jan; 34(1):116-7. PubMed ID: 11731954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.
    Razzolini F; Saladini F; Malincarne L; Vicenti I; Palladino N; Romano L; Francisci D; Zazzi M
    J Clin Microbiol; 2008 Nov; 46(11):3856-9. PubMed ID: 18845824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 4. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
    J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy.
    Murray JM
    J Infect Dis; 2003 Oct; 188(8):1258; author reply 1258-9. PubMed ID: 14551898
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child.
    Schmitz T; Kleinkauf N; Klempa B; Ringe H; Varnholt V; Grosch-Wörner I
    Pediatr Infect Dis J; 2006 Mar; 25(3):275-6. PubMed ID: 16511398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
    Montroni M; Monforte AD
    Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide transmission of drug-resistant HIV.
    Wensing AM; Boucher CA
    AIDS Rev; 2003; 5(3):140-55. PubMed ID: 14598563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.
    de Mendoza C; Rodriguez C; Eiros JM; Colomina J; Garcia F; Leiva P; Torre-Cisneros J; Aguero J; Pedreira J; Viciana I; Corral A; del Romero J; Ortiz de Lejarazu R; Soriano V
    Clin Infect Dis; 2005 Jul; 41(2):227-32. PubMed ID: 15983920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.
    Weinstock HS; Zaidi I; Heneine W; Bennett D; Garcia-Lerma JG; Douglas JM; LaLota M; Dickinson G; Schwarcz S; Torian L; Wendell D; Paul S; Goza GA; Ruiz J; Boyett B; Kaplan JE
    J Infect Dis; 2004 Jun; 189(12):2174-80. PubMed ID: 15181563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
    Leigh Brown AJ; Frost SD; Mathews WC; Dawson K; Hellmann NS; Daar ES; Richman DD; Little SJ
    J Infect Dis; 2003 Feb; 187(4):683-6. PubMed ID: 12599087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV drug-resistance cutoffs available.
    AIDS Read; 2000 Dec; 10(12):702. PubMed ID: 11189739
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 16. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
    Blick G; Kagan RM; Coakley E; Petropoulos C; Maroldo L; Greiger-Zanlungo P; Gretz S; Garton T
    J Infect Dis; 2007 May; 195(9):1250-9. PubMed ID: 17396993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral resistance testing comes of age.
    Hammer SM; Pedneault L
    Antivir Ther; 2000 Mar; 5(1):23-6. PubMed ID: 10846589
    [No Abstract]   [Full Text] [Related]  

  • 18. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
    Zolopa AR
    J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of HIV-1 drug resistance.
    Tang JW; Pillay D
    J Clin Virol; 2004 May; 30(1):1-10. PubMed ID: 15072747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.